Clinical trial
Prospective, Randomized Trial of Drug-eluting Stents vs. Bare Metal Stents for the Reduction of Restenosis in Bypass Grafts.
NCT00611910 is registered in ClinicalTrials.gov with Deutsches Herzzentrum Muenchen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective, Randomized Trial of Drug-eluting Stents vs. Bare Metal Stents for the Reduction of Restenosis in Bypass Grafts.
- Lead sponsor
- Deutsches Herzzentrum Muenchen
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 30, 2007
- Completion date
- March 31, 2011
- Enrollment
- 610 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
arteriosclerosis of arterial coronary artery bypass graft